IPP Bureau
Amazon.in launches a storefront for Ayurveda products
By IPP Bureau - February 11, 2022
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
OPPI-QCI announce awards to celebrate excellence in manufacturing facility 2021
By IPP Bureau - February 11, 2022
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets
By IPP Bureau - February 10, 2022
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences
By IPP Bureau - February 10, 2022
Adds five years of market exclusivity on approval
Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
By IPP Bureau - February 10, 2022
On track to complete the BLA submission in the first half of 2022
Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19
By IPP Bureau - February 10, 2022
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Skye Air Mobility to deploy drones to enhance Redcliffe Labs services
By IPP Bureau - February 10, 2022
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Basf, Orbia Ventures invest in Israeli biotech startup
By IPP Bureau - February 10, 2022
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Glenmark launches nasal spray to treat Covid-19
By IPP Bureau - February 09, 2022
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Scientists breaking barriers to treating heart failure
By IPP Bureau - February 09, 2022
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
TATA MD’s OmiSure detects all Omicron variants
By IPP Bureau - February 09, 2022
According to ICMR, the upgraded OmiSure RT-PCR test for Covid-19 successfully detects all sub-types of Omicron that are currently prevalent in India
EdiGene and Neukio collaborate to develop next-generation immune cell therapies
By IPP Bureau - February 09, 2022
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP
By IPP Bureau - February 09, 2022
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
C2i Genomics Partners with Twist Bioscience for cancer detection
By IPP Bureau - February 09, 2022
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Piramal Pharma Solutions plans expansion in Scotland
By IPP Bureau - February 09, 2022
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
